• About Pharmetheus
    • History
    • Mission & Values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
    • Contexts of use
      • Trial design and analysis
      • Program strategies and efficiences
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientists
      • Expert Advice
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence 
& Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
      • Training workshops
      • Publications
      • Case studies
      • Articles
    • Working with us
    • Open positions
    • Employee stories
    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Viviana Moroso brings scientific depth to quality control

    Viviana Moroso brings scientific depth to quality control

    Siv Jönsson develops Pharmetheus’s learning agenda

    Siv Jönsson develops Pharmetheus’s learning agenda

  • Events
  • News
  • Contact us
  1. Home
  2. News
  3. New office in Gothenburg to foster closer collaboration

Share on:

  • Facebook
  • LinkedIn

Pharmetheus opens new office in Gothenburg to foster closer collaboration

11.11.2026

Pharmetheus opens in Gothenburg
Pharmetheus opens in Gothenburg

To accommodate sustained growth and enable a closer collaboration with clients, Pharmetheus is expanding its presence in Sweden by opening a second office in Gothenburg. This addition complements Pharmetheus’s existing locations in Uppsala, Paris, and Utrecht, alongside a global network of remote specialists across Europe, North America, and Asia.

The Gothenburg office is located in Mölndal, a life science cluster centered around AstraZeneca and the rapidly growing GoCo Health Innovation City. This brings Pharmetheus closer to key partners, clients, and emerging biotech talent and pharmacology experts.

“I'm pleased that we have opened our new office in Gothenburg. It puts us close to many of our industry peers and clients, right in the center of West Sweden’s life science cluster. As we welcome new colleagues to the region, this is an important step for Pharmetheus,” says Jonas Möller, CEO of Pharmetheus.

Related content

Hyper-accelerated submission enables confident – and fast decisions for drug development teams and regulators

07/10/26

Hyper-accelerated submission enables confident – and fast decisions for drug development teams and regulators

Viewing pharmacometrics as merely one of the final steps in a multi-year process can be a fatal...

Stringency and clarity for confidence in Physiologically Based (PB) modeling

21/09/26

Stringency and clarity for confidence in Physiologically Based (PB) modeling

Author: Erik Sjögren, Scientific Lead for PBPK and PBBM

Peter Milligan, retiring CEO of Pharmetheus, wins 2026 ISoP Leadership Award

16/09/26

Peter Milligan, retiring CEO of Pharmetheus, wins 2026 ISoP Leadership Award

Following over seven years at the helm, outgoing CEO Peter Milligan leaves Pharmetheus on a high...


Contact

Pharmetheus AB
Kungsängstull 4 

753 19 Uppsala, Sweden

Visiting address: 

Dragarbrunnsgatan 77, 5th floor

  • LinkedIn
  • YouTube
  • Science & Services
    • Contexts of use
    • Pharmetheus Platforms
    • Solutions
    • Specific services
    • Publications
    • Case studies
  • Quick links
    • About us
    • Events
    • News
    • Careers
    • Contact us
    • Newsletter

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Gasell 2017
Gasell 2020
Gasell 2021
Gasell 2022
Gasell 2023
Gasell 2024

Copyright © Pharmetheus AB 2026

  • Whistleblower
  • Privacy Policy
  • Cookie Policy